Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Circ J ; 78(8): 1882-90, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24909891

RESUMO

BACKGROUND: Nobori is a novel biolimus A9-eluting stent (BES) coated with a biodegradable polymer only on the abluminal side, which degrades over 6-9 months post-stent deployment. The course of vessel reaction after deployment at these time points remains unclear. METHODS AND RESULTS: We serially evaluated 28 BES implanted in de novo coronary lesions of 23 patients using optical coherence tomography (OCT) at 6 and 12 months post-stenting. Standard OCT variables, the percentage of stent with peri-strut low-intensity area (PLIA, a region around stent struts homogenously showing lesser intensity than the surrounding tissue, suggesting fibrin deposition or impaired neointima maturation) and that with in-stent thrombi were evaluated. There was a significant, but small increase in neointimal thickness (72 ± 23 to 82 ± 25 µm, P=0.006) from the 6- to the 12-month follow-up, without a significant decrease in minimum lumen area (P=0.30). The incidences of uncovered and malapposed struts were low at 6 months and reduced further at 12 months (3.96 ± 3.97% to 1.51 ± 1.63%, P=0.001, and 0.50 ± 1.84% to 0.06 ± 0.24%, P=0.20, respectively). The frequency of stent with PLIA decreased during the follow-up (57% to 32%, P=0.05) and that with in-stent thrombi also numerically decreased (7% to 0%, P=0.24). CONCLUSIONS: Neointimal hyperplasia was persistently suppressed following BES implantation up to 12 months. Simultaneously, favorable vessel healing was achieved at 6 months without a delaying adverse reaction for up to 12 months.


Assuntos
Plásticos Biodegradáveis , Stents Farmacológicos , Regeneração , Sirolimo/análogos & derivados , Tomografia de Coerência Óptica , Idoso , Feminino , Seguimentos , Humanos , Hiperplasia/patologia , Hiperplasia/fisiopatologia , Masculino , Pessoa de Meia-Idade , Neointima/patologia , Neointima/fisiopatologia
2.
Can J Cardiol ; 31(8): 980-8, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26117623

RESUMO

BACKGROUND: The Nobori (Terumo Corporation, Tokyo, Japan) is a biolimus A9-eluting stent (BES) featured with a biodegradable polymer coated on the abluminal side only. We previously reported that favourable vessel healing was achieved at 6-12 months after BES implantation. However, detailed long-term vessel reaction after BES deployment is unclear. METHODS: Twenty-two BESs were serially evaluated using optical coherence tomography (OCT) at 6, 12, and 24 months after stenting. Average neointimal thickness, uncovered struts, and neointimal unevenness score (each cross-section as maximum neointimal thickness in 1 cross section divided by the average neointimal thickness of the same cross-section) were manually measured. In addition, we evaluated the percentage of struts with peri-strut low-intensity area (a region around stent struts that homogenously showed less intensity than the surrounding tissue, which suggests fibrin deposition or impaired neointima maturation), thrombi, and atherogenic neointimas (neointimas containing a diffuse border and poor-signal region with invisible struts due to marked signal attenuation). RESULTS: Serial OCT observation revealed a small gradual increase in neointimal thickness from 6 to 24 months (73 ± 24 µm; 81 ± 26 µm; and 108 ± 35 µm, respectively, P = 0.001) with a nonsignificant decrease in the lumen area (6.36 ± 1.98 mm(2); 6.18 ± 2.04 mm(2); and 5.87 ± 2.06 mm(2); P = 0.72). Frequency of uncovered struts (3.89 ± 3.91%; 1.55 ± 1.63%; and 0.23 ± 0.67%; P = 0.001), neointimal unevenness score (1.95 ± 0.18% to 1.86 ± 0.19% to 1.78 ± 0.17; P = 0.012), percentage of thrombi (5%, 0%, and 0%; P = 0.37) and peri-strut low-intensity area (6.8%, 5.1%, and 1.6%; P = 0.017) decreased from 6 to 12 and 24 months. Atherogenic neointima was not observed in the event-free OCT cohort. CONCLUSIONS: The Nobori stent achieved acceptable long-term vessel healing, mostly without adverse vessel reactions.


Assuntos
Materiais Revestidos Biocompatíveis , Doença da Artéria Coronariana/cirurgia , Vasos Coronários/patologia , Stents Farmacológicos , Polímeros , Sirolimo/análogos & derivados , Tomografia de Coerência Óptica/métodos , Idoso , Angiografia Coronária , Doença da Artéria Coronariana/diagnóstico , Vasos Coronários/cirurgia , Feminino , Seguimentos , Humanos , Masculino , Neointima , Estudos Prospectivos , Desenho de Prótese , Reprodutibilidade dos Testes , Sirolimo/farmacologia , Fatores de Tempo , Resultado do Tratamento
3.
Cardiovasc Interv Ther ; 27(3): 196-200, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22991143

RESUMO

Rupture of a silicon port catheter is a relatively rare complication and sometimes it is difficult to remove it. We experienced three cases of retrieval of silicone port catheters migrating into cardiac ventricle or pulmonary artery. Several devices such as a snare wire, an ablation catheter, and a basket catheter in combination with interventional guiding catheter were applied to retrieve them. These interventional techniques are applicable for retrieval of embolized vascular access port system and other catheter fragments.


Assuntos
Cateterismo Venoso Central/efeitos adversos , Embolia/cirurgia , Falha de Equipamento , Migração de Corpo Estranho/cirurgia , Ventrículos do Coração/cirurgia , Intervenção Coronária Percutânea/métodos , Artéria Pulmonar/cirurgia , Dispositivos de Acesso Vascular/efeitos adversos , Cateterismo Venoso Central/instrumentação , Embolia/complicações , Feminino , Coração , Humanos , Masculino , Pessoa de Meia-Idade , Silicones
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA